CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy

Approximately 20% of locally advanced rectal cancer (LARC) patients treated preoperatively with chemoradiotherapy (CRT) achieve pathologically confirmed complete regression. However, there are no clinically implemented biomarkers measurable in biopsies that are predictive of tumor regression. Here,...

Cijeli opis

Bibliografski detalji

Glavni autori:	Benita C. Y. Tse, Sarah Bergamin, Pascal Steffen, George Hruby, Nick Pavlakis, Stephen J. Clarke, Justin Evans, Alexander Engel, Andrew Kneebone, Mark P. Molloy
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2023-12-01
Serija:	OncoImmunology
Teme:	Dendritic cell immune cell immunophenotype neoadjuvant chemoradiotherapy rectal cancer
Online pristup:	https://www.tandfonline.com/doi/10.1080/2162402X.2023.2238506
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!